302 results
Page 4 of 16
8-K
EX-99.1
8tt 8wrj3z3k0y2m
5 Aug 20
Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer
4:07pm
8-K
EX-99.1
t5ox 9d0gg92dye
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
424B3
s5li17 s634h310qvjzz
29 Jun 20
Prospectus supplement
12:00am
424B5
dm73k y52gksc157
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-99.1
k38gp17 kacfaz
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
y762uiv09irphhkxd
7 May 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
4:09pm
424B5
irxxz0d870znn1ggoa
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-99.2
p5sh56 cd1
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
9c8evs
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am
424B5
gex x8qdl8
20 Mar 19
Prospectus supplement for primary offering
5:19pm
424B5
iagcig7
14 Mar 19
Prospectus supplement for primary offering
4:23pm